![Shankar Hariharan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shankar Hariharan
Direktor/Vorstandsmitglied bei DepYmed, Inc.
Profil
Shankar Hariharan is currently a Director at DepYmed, Inc. and an Advisor at New Rhein Healthcare Investors.
Previously, he worked as the Chief Scientific Officer and Executive VP at Amneal Intermediate, Inc. from 2010 to 2019.
He holds a doctorate degree from Northeastern University and an undergraduate degree from Banaras Hindu University.
Aktive Positionen von Shankar Hariharan
Unternehmen | Position | Beginn |
---|---|---|
DepYmed, Inc.
![]() DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Direktor/Vorstandsmitglied | - |
New Rhein Healthcare Investors
![]() New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Berater | - |
Ehemalige bekannte Positionen von Shankar Hariharan
Unternehmen | Position | Ende |
---|---|---|
Amneal Intermediate, Inc.
![]() Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 02.04.2019 |
Ausbildung von Shankar Hariharan
Northeastern University | Doctorate Degree |
Banaras Hindu University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
New Rhein Healthcare Investors
![]() New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
DepYmed, Inc.
![]() DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Health Technology |
Amneal Intermediate, Inc.
![]() Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |